SEEANN Secures Series A Investment to Scale Patient-Specific Implant Production

SEEANN, a South Korean startup specializing in patient-specific medical devices, has closed a Series A investment round from KB Securities, with additional investors being sought as the round remains open.

Founded in 2019, SEEANN designs and manufactures custom surgical devices based on individual patient medical imaging data. The company has developed its own 3D modeling and design software built on medical imaging, and has grown its market position through a full-cycle digital surgery platform capable of responding rapidly to clinical needs.

Its Class 2 medical device — a surgical guidance solution — is currently supplied to 54 major domestic healthcare institutions, including Seoul National University Hospital and Samsung Medical Center, establishing a strong track record in the field.

SEEANN has recently obtained three regulatory approvals for Class 3 patient-specific implants covering the skull, mandible, and spine — devices implanted directly into the human body and representing a significantly higher-value market segment. The company plans to use the proceeds from this round to build a dedicated Class 3 medical device production facility and substantially expand manufacturing capacity.

Going forward, SEEANN intends to broaden its product coverage to include the pelvis and femur, while pursuing regulatory clearances including U.S. FDA approval as part of its global expansion strategy